Profile
Nathan Stasko was the founder of NVN Liquidation, Inc. since 2006, serving as President, Director & Chief Scientific Officer from 2017 to 2019.
Dr. Stasko is currently the Chief Executive Officer & Director at Vast Therapeutics, Inc. since 2022.
Formerly, Dr. Stasko was a Director at KNOW Bio LLC.
Nathan Stasko active positions
| Companies | Position | Start |
|---|---|---|
Vast Therapeutics, Inc.
Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical stage biotechnology company which develops inhalable therapeutics to treat chronic infections | Chief Executive Officer | 2022-02-28 |
Former positions of Nathan Stasko
| Companies | Position | End |
|---|---|---|
| NVN LIQUIDATION, INC. | Chief Executive Officer | 2017-06-04 |
KNOW Bio LLC
KNOW Bio LLC Pharmaceuticals: MajorHealth Technology Develops and produces nitric oxide-based therapies | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
NVN Liquidation, Inc.
NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
KNOW Bio LLC
KNOW Bio LLC Pharmaceuticals: MajorHealth Technology Develops and produces nitric oxide-based therapies | Health Technology |
Vast Therapeutics, Inc.
Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical stage biotechnology company which develops inhalable therapeutics to treat chronic infections | Health Technology |
- Stock Market
- Insiders
- Nathan Stasko
















